Cart summary

You have no items in your shopping cart.

CAV3 Antibody (N-term)

Catalog Number: orb1930027

DispatchUsually dispatched within 5-10 working days
$ 140.00
Catalog Numberorb1930027
CategoryAntibodies
DescriptionPurified Rabbit Polyclonal Antibody (Pab)
TargetThis CAV3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 5-31 amino acids from the N-terminal region of human CAV3.
ClonalityPolyclonal
Species/HostRabbit
IsotypeRabbit IgG
ConjugationUnconjugated
ReactivityHuman
Predicted ReactivityMouse, Porcine, Rat
Form/AppearancePurified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
UniProt IDP56539
MW17259 Da
Tested applicationsFC, IHC-P, WB
Dilution rangeWB: 1:500, WB: 1:1000, IHC-P: 1:10~50, FC: 1:10~50
Antibody TypePrimary Antibody
Clone NumberRB19453
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Alternative namesCaveolin-3, M-caveolin, CAV3
NoteFor research use only
NCBINP_203123.1, NP_001225.1
CAV3 Antibody (N-term)

Western blot analysis of CAV3 antibody (N-term) in 293 cell line lysates (35 ug/lane). CAV3 (arrow) was detected using the purified Pab.

CAV3 Antibody (N-term)

Anti-CAV3 Antibody (N-term) at 1:500 dilution + human normal uterus lysates. Lysates/proteins at 20 µg per lane. Secondary Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/10000 dilution. Predicted band size: 17 kDa. Blocking/Dilution buffer: 5% NFDM/TBST.

CAV3 Antibody (N-term)

Flow cytometric analysis of 293 cells using CAV3 Antibody (N-term) (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.

CAV3 Antibody (N-term)

Formalin-fixed and paraffin-embedded human Skeletal muscle reacted with CAV3 Antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.